Search Results - "Zavala, German"

Abstract 16078: Pulmonary Vasculopathy Assessed By Intravascular Ultrasound in Persistent Pulmonary Hypertension After Mitral Valve Replacement, Comparation to Idiopathic Pulmonary Arterial Hypertension and Healthy Controls by Grignola, Juan Carlos J, Fernandez-Lopez, Leticia L, Domingo-Ribas, Enric E, Aguilar, Rio R, Arredondo, Cristian Humberto C, Zavala, German G, Roman, Antonio A

“…PurposeThe aim of the study is to assess pulmonary vasculopathy (wall fibrosis, pulmonary arterial pulsatility and elastic modulus ) in patients with…”
Get full text

Non-obstructive prosthetic heart valve thrombosis (NOPVT): Really a benign entity? by Mutuberría-Urdaniz, María, Rodríguez-Palomares, José F, Ferreira, Ignacio, Bañeras, Jordi, Teixidó, Gisela, Gutiérrez, Laura, Zavala, German, González-Alujas, Maria T, Evangelista, Artur, Tornos, Pilar, García-Dorado, David

“…Abstract Aims To assess the effectiveness of different treatment strategies in patients with non-obstructive prosthetic valve thrombosis (NOPVT) during…”
Get full text

Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2 by de la Torre Hernández, José M., Oteo Domínguez, Juan F., Hernández, Felipe, García Camarero, Tamara, Abdul-Jawad Altisent, Omar, Rivero Crespo, Fernando, Cascón, José D., Zavala, Germán, Gimeno, Federico, Arrebola Moreno, Antonio L., Andraka, Leire, Gómez Menchero, Antonio, Bosa, Francisco, Carrillo, Xavier, Sánchez Recalde, Ángel, Alfonso, Fernando, Pérez de Prado, Armando, López Palop, Ramón, Sanchis, Juan, Diarte de Miguel, José A., Jiménez Navarro, Manuel, Muñoz, Luz, Ramírez Moreno, Antonio, Tizón Marcos, Helena

“…The recommendation for dual antiplatelet therapy following drug-eluting stent implantation ranges from 6 months to 12 months or beyond. Recent trials have…”
Get full text

TCT-488 Risk of stent thrombosis with 6 vs. 12 months dual antiplatelet therapy after new generations drug-eluting stents implantation: final results of the multicenter prospective ESTROFA-DAPT study by De la Torre Hernandez, Jose M, Oteo Dominguez, Juan F, Hernandez, Felipe, Camarero, Tamara Garcia, Abdul-Jawad Altisent, Omar, Rivero-Crespo, Fernando, Cascon, Jose D, Zavala, German, Gimeno, Federico, Arrebola-Moreno, Antonio L, Andraka, Leire, Menchero, Antonio Gomez, Bosa, Francisco, Carrillo, Xavier, Sanchez-Recalde, Angel, Alfonso, Fernando, Pérez de Prado, Armando, Palop, Ramon Lopez, Sanchis, Juan, Diarte de Miguel, José A, De Lemos, Rocio, Muñoz, Luz, Moreno, Antonio Ramirez, Tizon-Marcos, Helena

“…Patients to include should meet at least one of the following criteria: silent ischemia, stable angina, low risk acute coronary syndrome (ACS) or any ACS with…”
Get full text

TCT-140 Prospective Multicenter Registry of 6 Months Dual Antiplatelet Therapy after new Generation Drug-eluting Stent Implantation: ESTROFA-DAPT Study by De la Torre Hernandez, Jose M, Oteo Dominguez, Juan F, Hernandez, Felipe, Abdul-Jawad Altisent, Omar, Rivero-Crespo, Fernando, Cascon, Jose D, Arrebola, Antonio L, Gimeno, Federico, Zavala, German, Andraka, Leire, Gomez Menchero, Antonio, Bosa, Francisco, Carrillo, Xavier, De Lemos, Rocio, Ramirez Moreno, Antonio, Castillo, Jose L, Sanchez-Recalde, Angel, Tizon-Marcos, Helena

Get full text

Ain't How You Deploy: An Analysis of BGP Security Policies Performance Against Various Attack Scenarios with Differing Deployment Strategies by Barrett, Seth, Idom, Calvin, Villafuerte, German Zavala, Byers, Andrew, Gulmezoglu, Berk

“…This paper investigates the performance of various Border Gateway Protocol (BGP) security policies against multiple attack scenarios using different deployment…”
Get full text

Análisis de la propuesta de nueva Constitución a la luz de principios del constitucionalismo by Rosales Rigol, Cecilia, Cea Egaña, José Luis, Romero Guzmán, Juan José, Concha Zavala, Germán, Soto Velasco, Sebastián, Fermandois Vöhringer, Arturo, Ovalle Valdés, Alejandra

Get full text

Terapia antiplaquetaria doble de 6 o de 12 meses tras implante de stents farmacoactivos de nueva generación: análisis emparejado de los registros ESTROFA-DAPT y ESTROFA-2 by de la Torre Hernández, José M, Oteo Domínguez, Juan F, Hernández, Felipe, García Camarero, Tamara, Abdul-Jawad Altisent, Omar, Rivero Crespo, Fernando, Cascón, José D, Zavala, Germán, Gimeno, Federico, Arrebola Moreno, Antonio L, Andraka, Leire, Gómez Menchero, Antonio, Bosa, Francisco, Carrillo, Xavier, Sánchez Recalde, Ángel, Alfonso, Fernando, Pérez de Prado, Armando, López Palop, Ramón, Sanchis, Juan, Diarte de Miguel, José A, Jiménez Navarro, Manuel, Muñoz, Luz, Ramírez Moreno, Antonio, Tizón Marcos, Helena

“…Resumen Introducción y objetivos El periodo de uso recomendado del tratamiento antiagregante plaquetario combinado doble tras implante de stents farmacoactivos…”
Get full text